These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 8887465)
1. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Mann S; Droz PO; Vahter M Toxicol Appl Pharmacol; 1996 Oct; 140(2):471-86. PubMed ID: 8887465 [TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic modeling of arsenic in the mouse. Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111 [TBL] [Abstract][Full Text] [Related]
3. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Mann S; Droz PO; Vahter M Toxicol Appl Pharmacol; 1996 Mar; 137(1):8-22. PubMed ID: 8607145 [TBL] [Abstract][Full Text] [Related]
4. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Meza MM; Kopplin MJ; Burgess JL; Gandolfi AJ Environ Res; 2004 Oct; 96(2):119-26. PubMed ID: 15325872 [TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920 [TBL] [Abstract][Full Text] [Related]
6. A physiologically based pharmacokinetic model of inorganic arsenic. Yu D Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):128-41. PubMed ID: 10341143 [TBL] [Abstract][Full Text] [Related]
7. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. Golub MS; Macintosh MS; Baumrind N J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328 [TBL] [Abstract][Full Text] [Related]
8. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water. Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777 [TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats. Adair BM; Moore T; Conklin SD; Creed JT; Wolf DC; Thomas DJ Toxicol Appl Pharmacol; 2007 Jul; 222(2):235-42. PubMed ID: 17559899 [TBL] [Abstract][Full Text] [Related]
10. A biokinetic model to describe the distribution and excretion of arsenic by man following acute and chronic intakes of arsenite/arsenate compounds by ingestion. Adeyemi A; Garelick H; Priest ND Hum Exp Toxicol; 2010 Nov; 29(11):891-902. PubMed ID: 20219843 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development. Stump DG; Holson JF; Fleeman TL; Nemec MD; Farr CH Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206 [TBL] [Abstract][Full Text] [Related]
12. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952 [TBL] [Abstract][Full Text] [Related]
13. Assessing the cancer risk associated with arsenic-contaminated seafood. Chen BC; Chou WC; Chen WY; Liao CM J Hazard Mater; 2010 Sep; 181(1-3):161-9. PubMed ID: 20546995 [TBL] [Abstract][Full Text] [Related]
14. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Xie Y; Trouba KJ; Liu J; Waalkes MP; Germolec DR Environ Health Perspect; 2004 Aug; 112(12):1255-63. PubMed ID: 15345372 [TBL] [Abstract][Full Text] [Related]
15. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Sakurai T; Kaise T; Matsubara C Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations. El-Masri HA; Hong T; Henning C; Mendez W; Hudgens EE; Thomas DJ; Lee JS Environ Health Perspect; 2018 Jul; 126(7):077004. PubMed ID: 30024383 [TBL] [Abstract][Full Text] [Related]
17. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Caceres DD; Pino P; Montesinos N; Atalah E; Amigo H; Loomis D Environ Res; 2005 Jun; 98(2):151-9. PubMed ID: 15820720 [TBL] [Abstract][Full Text] [Related]
18. Quantitative imaging of arsenic and its species in goat following long term oral exposure. Patra PH; Bandyopadhyay S; Kumar R; Datta BK; Maji C; Biswas S; Dash JR; Sar TK; Sarkar S; Manna SK; Chakraborty AK; Mandal TK Food Chem Toxicol; 2012 Jun; 50(6):1946-50. PubMed ID: 22497900 [TBL] [Abstract][Full Text] [Related]
19. Urinary arsenic speciation profiles in mice subchronically exposed to low concentrations of sodium arsenate in drinking water. Wu H; Krishnamohan M; Lam PK; Ng JC Kaohsiung J Med Sci; 2011 Sep; 27(9):417-23. PubMed ID: 21914530 [TBL] [Abstract][Full Text] [Related]
20. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure. Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]